Genvoya 150 mg - 150 mg - 200 mg - 10 mg (cobicistat 150 mg + elvitegravir 150 mg + emtricitabine 200 mg + tenofovir alafenamide 10 mg tablet (or.)) · CNK 4201877

Product information

Genvoya 150 mg - 150 mg - 200 mg - 10 mg
30
cobicistat 150 mg + elvitegravir 150 mg + emtricitabine 200 mg + tenofovir alafenamide 10 mg tablet (or.)
4201877
2.31 / 10
Locked

Product properties

1004316-88-4
J05AR18
Gilead Sciences Ireland UC
Film-coated tablet
€773.38
EU/1/15/1061/001
08718969845458
M42
Public
485084-02

Pharmacist Assessment

Structurally fluctuating availability

This product has chronically fluctuating availability (current 2.31/10, historical 🔒/10). Be prepared for possible supply issues and consider keeping an alternative in stock.

Equivalent products

Tier A: Direct equivalents

Tier B: Galenic alternatives

Tier C: Strength alternatives

Tier D: ATC equivalents (parallel import)

Tier E: Active substances (magistral)

Stock overview

Availability in Freemium
  • 5 of 18 warehouse locations have stock
  • 1 of the 3 wholesalers have stock

Detailed stock insights are available for registered users

Create a free Curadar Freemium account to view detailed stock data from Febelco, Phoenix and CERP.

Status history (PharmaStatus)

Available Active
Published 20/11/2025

Composition

6 ingredients

Substance Type Strength CAS
Active ingredient
150 mg
1004316-88-4
Active ingredient
150 mg
697761-98-1
Active ingredient
1392275-56-7
Active ingredient
200 mg
143491-57-0
Excipient
60 mg
Excipient

Additional information

Availability statistics

Available
0 days
2
0